Why the study?
Does corticotropin alone or in combination with colchicine improve efficacy and safety compared to indomethacin in patients with acute gout?
Does corticotropin alone or in combination with colchicine improve efficacy and safety compared to indomethacin in patients with acute gout?
Corticotropin may be considered an alternative for acute gout management, especially in patients with contraindications to standard therapies.
May support corticotropin as alternative for acute gout with NSAID contraindications; leaves open need for randomized confirmation.
OBJECTIVE: To evaluate safety and efficacy of corticotropin for acute gout. DATA SOURCES: Clinical literature was accessed through MEDLINE (1966-August 2000). Key search terms included gout, ACTH, adrenocorticotropic hormone, and corticotropin. DATA SYNTHESIS: Joint pain and local signs of inflammation characterize gout. Acutely, colchicine and nonsteroidal antiinflammatory drugs (NSAIDs) are first-line therapy. Adverse effects or concomitant diseases limit therapy and necessitate alternative options. An evaluation of studies involving corticotropin was conducted. CONCLUSIONS: Corticotropin alone or in combination with colchicine was more rapidly effective and associated with fewer adverse effects than indomethacin. This regimen may be considered an alternative, especially for patients with medical problems in which other regimens are contraindicated.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: